Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which of the following immunosuppressive agents has a side effect of osteoporosis?

Glucocorticoids. **Explanation:** **Glucocorticoids** (Option C) are the primary cause of drug-induced osteoporosis. They induce bone loss through a multi-factorial mechanism: 1. **Direct Inhibition:** They inhibit osteoblast (bone-forming cells) activity and increase osteoclast (bone-resorbing cells) lifespan. 2. **Calcium Homeostasis:** They decrease intestinal calcium absorption and increase renal calcium excretion. 3. **Hormonal Impact:** They suppress the gonadotropin-releasing hormone, leading to lower levels of estrogen and testosterone, which are essential for maintaining bone density. **Analysis of Incorrect Options:** * **Cyclophosphamide (Option A):** An alkylating agent primarily known for **hemorrhagic cystitis** (prevented by Mesna) and gonadotoxicity. While it can cause premature menopause (leading to secondary bone loss), it is not directly osteoporotic like steroids. * **Methotrexate (Option B):** An antimetabolite (DHFR inhibitor). Its hallmark toxicities include **myelosuppression**, hepatotoxicity, and pulmonary fibrosis. "Methotrexate osteopathy" is rare and typically only seen with high-dose chemotherapy, not standard immunosuppressive doses. * **Mycophenolate Mofetil (Option D):** An IMPDH inhibitor used in transplants. Its main side effects are **gastrointestinal distress** (diarrhea) and bone marrow suppression. It does not affect bone mineral density. **NEET-PG High-Yield Pearls:** * **Glucocorticoid-Induced Osteoporosis (GIOP):** It is the most common cause of secondary osteoporosis. Bone loss is most rapid in the first 6 months of therapy. * **Prophylaxis:** Patients on long-term steroids (>3 months) should be started on **Bisphosphonates** (e.g., Alendronate) along with Calcium and Vitamin D supplements. * **Other Steroid Side Effects:** Cushingoid features, hyperglycemia, cataracts, avascular necrosis of the femoral head, and psychosis.

Q: Pink disease or acrodynia is seen with exposure to which of the following?

Mercury. **Explanation:** **Pink disease**, also known as **Acrodynia**, is a hypersensitivity reaction (Type IV) occurring primarily in children exposed to **Mercury** (elemental or inorganic). Historically, it was associated with the use of calomel in teething powders and mercurial ointments. **Why Mercury is correct:** The condition is characterized by a distinctive clinical triad: 1. **Dermatological:** Pinkish discoloration of the hands and feet (hence the name), accompanied by desquamation and painful swelling. 2. **Neurological:** Irritability, photophobia, and hypotonia. 3. **Autonomic:** Profuse sweating (diaphoresis) and hypertension due to mercury’s interference with the catecholamine degradation pathway (COMT inhibition). **Why other options are incorrect:** * **Arsenic:** Chronic poisoning typically presents with "raindrop" pigmentation, hyperkeratosis of palms/soles, and Mees' lines on nails. It is associated with lung and skin cancers (Bowen’s disease). * **Copper:** Excess accumulation leads to **Wilson’s Disease**, characterized by Kayser-Fleischer (KF) rings in the cornea and basal ganglia degeneration. * **Lead:** Chronic toxicity (Plumbism) presents with microcytic anemia (basophilic stippling), "Burtonian lines" on gums, and wrist/foot drop due to peripheral neuropathy. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of choice for Acrodynia:** Dimercaprol (BAL) or Succimer (DMSA). * **Minamata Disease:** Caused by organic mercury (Methylmercury) consumption via contaminated fish. * **Erethism:** A neuropsychiatric syndrome (shyness, tremors, irritability) seen in chronic mercury vapor inhalation, historically known as "Mad Hatter’s Syndrome."

Q: What is the treatment of choice for opioid poisoning?

Intravenous naloxone. **Explanation:** **1. Why Intravenous Naloxone is the Correct Answer:** Opioid poisoning is a medical emergency characterized by the "classic triad": respiratory depression, pinpoint pupils (miosis), and coma. **Naloxone** is a pure opioid antagonist that competes for $\mu$, $\kappa$, and $\delta$ receptors, rapidly reversing the life-threatening respiratory depression. In an acute emergency, the **intravenous (IV)** route is preferred because it provides the fastest onset of action (1–2 minutes). **2. Why the Other Options are Incorrect:** * **Oral Naltrexone:** While naltrexone is also an opioid antagonist, it has a long duration of action and is primarily used for the **maintenance of abstinence** in recovered addicts. Its oral administration and slow onset make it unsuitable for acute toxicity. * **Oral Diazepam:** Diazepam is a benzodiazepine (sedative-hypnotic). Administering it in opioid poisoning would worsen CNS and respiratory depression, potentially leading to death. * **Oral Buprenorphine:** This is a partial $\mu$-agonist. While used in opioid substitution therapy, it can precipitate withdrawal in dependent individuals and will not effectively reverse a massive overdose. **3. High-Yield Clinical Pearls for NEET-PG:** * **Short Half-life:** Naloxone has a shorter half-life (approx. 60–90 mins) than most opioids (e.g., Morphine, Methadone). Therefore, **repeated dosing or a continuous IV infusion** is often required to prevent "re-narcotization." * **Diagnostic Use:** Naloxone is used in the "Coma Cocktail" for patients with an unknown cause of unconsciousness. * **Withdrawal:** In opioid-dependent patients, naloxone can precipitate an acute, severe withdrawal syndrome (shivering, gooseflesh, lacrimation). * **Exception:** Mydriasis (dilated pupils) rather than miosis is seen in **Pethidine** poisoning due to its atropine-like action.

Q: What is the antidote for Alprazolam?

Flumazenil. **Explanation:** **Correct Answer: B. Flumazenil** Alprazolam is a **Benzodiazepine (BZD)** [3]. Benzodiazepines work by enhancing the effect of GABA (the primary inhibitory neurotransmitter) at the GABA-A receptor by increasing the frequency of chloride channel opening [4]. **Flumazenil** is a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor complex [1], [2]. It rapidly reverses the sedative effects of BZDs, making it the specific antidote for overdose or for reversing conscious sedation [1]. **Incorrect Options:** * **A. Protamine sulphate:** This is the specific antidote for **Heparin** overdose. It is a positively charged molecule that neutralizes negatively charged heparin through ionic bonding. * **C. EDTA (Ethylenediaminetetraacetic acid):** This is a chelating agent used primarily for **Lead poisoning**. * **D. BAL (British Anti-Lewisite/Dimercaprol):** This is a chelating agent used for heavy metal poisoning, specifically **Arsenic, Mercury, and Gold**. **High-Yield Clinical Pearls for NEET-PG:** * **Seizure Risk:** The most significant risk of administering Flumazenil is the precipitation of **seizures**, especially in patients with chronic BZD dependence or co-ingestion of TCAs (Tricyclic Antidepressants) [2]. * **Short Half-life:** Flumazenil has a very short half-life (approx. 1 hour). Since most BZDs (like Diazepam) last longer, **resedation** can occur, requiring repeated doses or a continuous infusion. * **Mechanism Reminder:** BZDs increase the *frequency* of channel opening, while Barbiturates increase the *duration*. Flumazenil does **not** reverse Barbiturate toxicity [1].

Q: Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Carbamazepine - Breech presentation. **Explanation:** This question tests knowledge of the teratogenic and systemic adverse effects of common antiepileptic drugs (AEDs). **1. Why Option B is the Correct Answer:** **Carbamazepine** is associated with **Neural Tube Defects (NTDs)**, craniofacial abnormalities, and fingernail hypoplasia. **Breech presentation** is a mechanical obstetric complication related to fetal positioning and is **not** a drug-induced malformation or a recognized adverse effect of Carbamazepine. Therefore, this statement is false. **2. Analysis of Incorrect Options (True Statements):** * **A. Phenobarbitone - Cardiovascular defect:** Phenobarbitone is a known teratogen. Maternal use is associated with congenital heart diseases (e.g., septal defects) and the "Fetal Hydantoin-like Syndrome." * **C. Phenytoin - Gum hyperplasia [1]:** This is a classic, high-yield side effect occurring in about 50% of patients. It is caused by the stimulation of platelet-derived growth factor (PDGF) and fibroblast proliferation. * **D. Sodium valproate - Neural tube defect:** Valproate has the highest teratogenic risk among AEDs. It interferes with folate metabolism, leading specifically to **spina bifida** (incidence ~1-2%). **3. High-Yield Clinical Pearls for NEET-PG:** * **Fetal Hydantoin Syndrome (Phenytoin):** Characterized by cleft lip/palate, microcephaly, and hypoplastic phalanges/nails. * **Valproate:** Most common cause of NTDs; supplementation with high-dose Folic Acid (5mg) is mandatory for women of childbearing age on AEDs. * **Drug of Choice (DOC) in Pregnancy:** **Lamotrigine** and **Levetiracetam** are currently considered the safest AEDs regarding major malformations. * **Enzyme Induction:** Phenytoin, Carbamazepine, and Phenobarbital are potent **CYP450 inducers**, which can lead to Vitamin K deficiency in the neonate (causing hemorrhagic disease of the newborn).

Q: What is the condition known as "Blue Man Syndrome"?

Argyria. **Explanation:** **Argyria (Option B)** is the correct answer. It is a rare clinical condition caused by chronic exposure to or ingestion of **silver salts**. Silver particles deposit in the skin, mucous membranes, and internal organs. Upon exposure to sunlight, these silver deposits undergo a photochemical reaction (similar to photography), resulting in a characteristic, irreversible **slate-grey to bluish discoloration** of the skin, often referred to as **"Blue Man Syndrome."** **Analysis of Incorrect Options:** * **Acrodynia (Option A):** Also known as "Pink Disease," this is a manifestation of chronic **mercury poisoning**, primarily seen in children. It presents with pinkish discoloration of the hands and feet, irritability, and polyneuropathy, rather than blue skin. * **Plumbism (Option C):** This is the medical term for **lead poisoning**. Clinical hallmarks include the "Burtonian line" (bluish-purple line on the gums), abdominal colic, wrist drop/foot drop, and microcytic hypochromic anemia with basophilic stippling. It does not cause generalized blue skin. **High-Yield Clinical Pearls for NEET-PG:** * **Amiodarone:** This anti-arrhythmic drug is a common pharmacological cause of **"Blue-grey skin pigmentation"** due to iodine deposits and lipofuscin accumulation in the skin. * **Differential Diagnosis:** Always differentiate Blue Man Syndrome from **Methemoglobinemia**, where the skin appears cyanotic/blue due to oxidized hemoglobin (Fe³⁺) which cannot bind oxygen. * **Treatment of Argyria:** There is no effective systemic cure; treatment is primarily preventive. Laser therapy (Q-switched Nd:YAG) has shown some success in reducing skin pigmentation.

Q: Which drug causes Addison's disease?

Ketoconazole. **Explanation:** **Ketoconazole** is the correct answer because it is a potent inhibitor of steroidogenesis. It inhibits several cytochrome P450 enzymes, most notably **11β-hydroxylase** and **17,20-lyase**, which are essential for the synthesis of cortisol and adrenal androgens. Prolonged or high-dose use can lead to primary adrenal insufficiency, clinically manifesting as **Addison’s disease**. **Analysis of Options:** * **Ketoconazole (A):** Directly blocks cortisol synthesis. While used therapeutically to treat Cushing’s syndrome, its side effect profile includes adrenal suppression and hepatotoxicity. * **Aminoglutethimide (B):** While it inhibits the conversion of cholesterol to pregnenolone (blocking all steroid synthesis), it is primarily used to treat breast cancer or Cushing’s. However, in the context of standard NEET-PG questions, Ketoconazole is the classic prototype drug cited for causing clinical adrenal insufficiency. * **Cyclosporine (C):** This is an immunosuppressant (calcineurin inhibitor). Its primary toxicities are nephrotoxicity and gingival hyperplasia, not adrenal suppression. * **Glucocorticoids (D):** Chronic administration causes **Secondary Adrenal Insufficiency** (due to HPA axis suppression) upon abrupt withdrawal. It does not cause Addison’s disease (Primary Adrenal Insufficiency) while the drug is being administered; rather, it causes Cushingoid features. **High-Yield Clinical Pearls for NEET-PG:** * **Ketoconazole** also causes **Gynecomastia** and decreased libido in males due to the inhibition of androgen synthesis. * **Drug of choice for Cushing’s Syndrome:** Ketoconazole is often the preferred medical management to rapidly lower cortisol levels. * **Etomidate:** An intravenous anesthetic agent that also inhibits 11β-hydroxylase and can cause transient adrenal suppression after a single dose.

Question 1

Which of the following immunosuppressive agents has a side effect of osteoporosis?

Accepted Answer

Glucocorticoids

Answer

Cyclophosphamide

Answer

Methotrexate

Answer

Mycophenolate mofetil

Question 2

Pink disease or acrodynia is seen with exposure to which of the following?

Accepted Answer

Mercury

Answer

Arsenic

Answer

Copper

Answer

Lead

Question 3

What is the treatment of choice for opioid poisoning?

Accepted Answer

Intravenous naloxone

Answer

Oral naltrexone

Answer

Oral diazepam

Answer

Oral buprenorphine

Question 4

What is the antidote for Alprazolam?

Accepted Answer

Flumazenil

Answer

Protamine sulphate

Answer

EDTA

Answer

BAL

Question 5

Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Accepted Answer

Carbamazepine - Breech presentation

Answer

Phenobarbitone - Cardiovascular defect

Answer

Phenytoin - Gum hyperplasia

Answer

Sodium valproate - Neural tube defect

Question 6

What is the mechanism of action of ethanol in methyl alcohol poisoning?

Accepted Answer

Competitively inhibits alcohol dehydrogenase

Answer

Selectively inhibits catalase

Answer

Competitively inhibits lactate dehydrogenase

Answer

Competitive inhibition of acetaldehyde dehydrogenase

Question 7

What is the condition known as "Blue Man Syndrome"?

Accepted Answer

Argyria

Answer

Acrodynia

Answer

Plumbism

Answer

None of the above

Question 8

Which drug causes Addison's disease?

Accepted Answer

Ketoconazole

Answer

Aminoglutethimide

Answer

Cyclosporine

Answer

Glucocorticoids

Question 9

A herpetologist is bitten by a poisonous snake and is taken to the emergency department with progressive muscle paralysis. The venom is probably affecting which of the following?

Accepted Answer

Acetylcholine receptors

Answer

Na+ channels

Answer

Ca2+ channels

Answer

Phospholipids

Question 10

Why is therapeutic drug monitoring of theophylline clinically used in asthma?

Accepted Answer

It has a narrow therapeutic margin.

Answer

It causes idiosyncrasy.

Answer

It is nephrotoxic.

Answer

It decreases histamine.

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?